Primary study · included by 1 review

Direct pulp capping in primary molars using a resin-modified Portland cement-based material (TheraCal) compared to MTA with 12-month follow-up: a randomised clinical trial.

Erfanparast 2018 · Erfanparast L, Iranparvar P, Vafaei A · European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2018

Included by

Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry.

Non-Cochrane · intervention · 2026 · cited as Erfanparast 2018 · Table 2; Reference 44

Outcome this study informs	Pooled effect	Evidence	Certainty
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · <360 days	RR 0.99 [0.96, 1.02]	7 studies · 400 participants	Low
Overall clinical and radiographic success TheraCal LC (resin-modified calcium silicate) in vital pulp therapy (ipc, dpc, pulpotomy) vs Non-resin calcium silicate materials (MTA ProRoot, MTA Angelus, Biodentine) · >=360 days	RR 0.95 [0.89, 1.01]	5 studies · 355 participants	Low

1 including review in total.